Cannabinor, a Selective Cannabinoid-2 Receptor Agonist, Improves Bladder Emptying in Rats With Partial Urethral Obstruction.
PURPOSE:: We studied the effects of chronic treatment with the novel selective cannabinoid 2 receptor agonist cannabinor (Procter&Gamble Pharmaceuticals, Cincinnatti, Ohio) on bladder function in conscious rats with partial urethral obstruction and on the functional properties of isolated detrusor muscle. MATERIALS AND METHODS:: A total of 24 female Sprague-Dawley® rats with surgically created